Sanjay Ahuja Appointed CEO and Medical Director of Innovative Hematology
Sanjay Ahuja, Chief Medical Officer, CEO and Medical Director of Innovative Hematology, Inc., shared Innovative Hematology, Inc.‘s post on LinkedIn:
“I am deeply grateful for this opportunity, and both honored and humbled by the responsibility it carries.
As I reflect on this moment, I’m reminded that none of us walks this path alone. We stand on the shoulders of those who came before us, lean on those who walk alongside us, and have a responsibility to lift those who follow.
Thankful for the mentors, colleagues, and teams who have made this journey possible
As I look ahead, I’m inspired by the opportunity to build, to serve, and to create something that meaningfully improves the lives of our patients we are so privileged to serve.
The work continues—and the best is still ahead.”
Innovative Hematology, Inc. shared a post on LinkedIn:
“Today marks Dr. Sanjay Ahuja‘s first day as Medical Director and CEO of Innovative Hematology.
As we look ahead, our focus now is clear:
to build on the strong foundation already in place, strengthen the continuity of care our patients depend on, and position IHI for thoughtful and sustainable growth.
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL
-
Apr 22, 2026, 15:28ASH Committee Brings the Voice of Hematology to Capitol Hill
-
Apr 22, 2026, 15:22Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly, But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden